✦ LIBER ✦

Favorable Outcomes in Elderly and High-Risk Patients with AML and MDS Following T-Cell Depleted Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation

✍ Scribed by E. Nicholson; S. Mackinnon; K.J. Thomson; J. Sudak; A.K. Fielding; P. Kottaridis; K.S. Peggs; E.C. Morris; R. Chakraverty

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Favorable Outcomes in Patients with High

✍ Amir A. Toor; Roy T. Sabo; Harold M. Chung; Catherine Roberts; Rose H. Manjili; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 462 KB

Busulfan Does Intensity and Outcomes in

✍ Chen, Yi-Bin; Coughlin, Erin; Cutler, Corey; Kennedy, Kevin; Alyea, Edwin P.; Ar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Combined Risk-Factor Analysis Predicts O

✍ P.G. Hemmati; T.H. Terwey; G. Massenkeil; P. le Coutre; S. Neuburger; B. Dorken; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Outcomes of patients with AML and MDS wh

✍ Pollyea, D A; Artz, A S; Stock, W; Daugherty, C; Godley, L; Odenike, O M; Rich, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Allogeneic hematopoietic stem-cell trans

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Yerushalmi, R; Nagler, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 188 KB

Outcome of High-Risk and Refractory AML/

✍ M. Detrait; P. Chevallier; M. Sobh; T. Guillaume; X. Thomas; S. Morisset; N. Ted 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB